# Indokem share price today (Indokem Ltd, NSE: INDOKEM) > Indokem share price today: ₹628.40 at the NSE close on 3 November 2026, down 9.3% in a year. Indokem (NSE: INDOKEM) is worth ₹1,752 crore, trades at a P/E of 782.1 and has closed between ₹462.85 and ₹878.25 over the past 52 weeks. > Indokem Ltd's share price has risen faster than its earnings: −9.3% in a year, against −41.2% for earnings per share. INDOKEM · Dyes & Pigments · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/indokem-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Price: ₹628.40 (−9.3% in a year) - P/E: 782.1× (higher than 87% of the last 1 year) - Revenue (Jun 2026): ₹46.6 Cr (+12.2% on a year ago) - Profit (Jun 2026): ₹1.1 Cr (+52.9% on a year ago) - Operating margin: 4.8% (+0.5 points on a year ago) - ROCE: 5%, FY26 - ROIC: 4.9%, against a 12.0% cost of capital: −7.1 points - Profit that came in as cash: −67%, last 3 years The main question: profits are rising, but only −67% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Indokem share price today? Indokem Ltd's share price was ₹628.40 at the close on 3 November 2026. It has been rising for 11 weeks. That is 7.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹463 and ₹878, and at that close it sat 40% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 10 weeks in a row. Over the last 11 years the share price moved +14,149% while the NIFTY 500 moved +241%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Indokem this quarter? Two changes stood out: profit grew again in the June 2026 quarter and revenue grew again in the June 2026 quarter. 1. Profit grew again in the June 2026 quarter Profit was ₹1 crore, +52.9% on a year earlier (₹1 crore), after 2 quarters of decline. 2. Revenue grew again in the June 2026 quarter Revenue was ₹47 crore, +12.2% on a year earlier (₹42 crore), after 3 quarters of decline. ## What are Indokem's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Indokem reported revenue of ₹46.6 crore, up 12.2% from ₹41.6 crore a year earlier, and a profit of ₹1.07 crore, up 52.9% from ₹0.70 crore. ### Indokem results: April to June 2026 against a year earlier | Measure | April to June 2026 | April to June 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹46.6 crore | ₹41.6 crore | +12.2% | | Profit | ₹1.07 crore | ₹0.70 crore | +52.9% | | Earnings per share | ₹0.38 | ₹0.25 | +52.0% | | Operating margin | 4.8% | 4.3% | +0.5 points | The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.) ## What is the Indokem share price history? Indokem closed at ₹628.40 on 3 November 2026, down 9.3% from ₹692.85 a year earlier (31 October 2025) and up 1,542.9% over five years. Its highest weekly close since March 2016 was ₹878.25 on 14 November 2025. ### Indokem share price: then and now | When | Close | Change to 3 Nov 2026 | | --- | --- | --- | | 1 week ago · 23 Oct 2026 | ₹620.10 | +1.3% | | 1 month ago · 1 Oct 2026 | ₹602.15 | +4.4% | | 1 year ago · 31 Oct 2025 | ₹692.85 | −9.3% | | 3 years ago · 3 Nov 2023 | ₹117.90 | +433.0% | | 5 years ago · 4 Nov 2021 | ₹38.25 | +1,542.9% | | 10 years ago · 4 Nov 2016 | ₹14.86 | +4,128.8% | | Earliest weekly close in our records · 18 Mar 2016 | ₹4.41 | +14,149.4% | | Highest weekly close since March 2016, also the 52-week high · 14 Nov 2025 | ₹878.25 | −28.4% | | Lowest weekly close since March 2016 · 30 Mar 2016 | ₹3.80 | +16,436.8% | | 52-week low (weekly close) · 13 Mar 2026 | ₹462.85 | +35.8% | Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (539 weekly closes from 18 March 2016 to 3 November 2026.) ## What is the latest news on Indokem? 3 Nov 2026: Indokem closed at ₹628.40, up 1.3% on the week and up 4.4% on the month. Results for April to June 2026: Revenue up 12.2% and profit up 52.9% on a year earlier. ## What dividend does Indokem pay? Indokem has paid no dividend on the NSE since 1 April 2021, the start of the period we checked. No. Indokem Ltd paid out 0% of its profit as dividends in each of its last 10 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.) ## Which stock lists is Indokem on? Indokem is on one of our India lists: Momentum stocks. [Momentum stocks Market cap cr: 1755.697592895536](https://www.sectoralpha.in/momentum-stocks-india) ## Is Indokem profitable? Indokem Ltd earned ₹1.1 Cr of net profit in the Jun 2026 quarter, +52.9% on the same quarter a year earlier. Full-year FY26 profit was ₹2.0 Cr. Over 20 years profit has grown 3.5% a year on average. That is 2.3% of the quarter's revenue. The same quarter a year earlier earned ₹0.7 Cr. 5 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹2.0 Cr (−33.3% on the year before). Why profit moved: revenue changed +12.2% on a year earlier and the margin moved +0.5 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −27.8% and revenue −3.6%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Indokem make, and is it growing? Indokem Ltd reported ₹46.6 Cr of revenue in the Jun 2026 quarter, +12.2% on the same quarter a year earlier. Over 20 years it has grown 4.7% a year on average. The last full year, FY26, came in at ₹169 Cr. The last four reported quarters add to ₹174 Cr. FY26 revenue was ₹169 Cr, −5.1% on the year before. Recent pace: the last four quarters grew −3.6% on average, against 4.7% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −4.5%, against +5.2% a year over the last 8 quarters (rolling over). ## How much of every ₹100 of sales does Indokem keep? Indokem Ltd's operating margin was 4.8% in the Jun 2026 quarter, 0.5 percentage points higher than the same quarter a year ago. Across 10 years it has been between −41.0% and 10.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +0.5 percentage points on the year while gross margin changed +1.1 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Indokem's profit turning into cash? Over the last 3 years Indokem Ltd's operations used more cash than they brought in, so cash conversion was −67%, a gap worth watching. In FY26 its operations used ₹4.0 Cr of cash, against ₹2.0 Cr of profit. After −₹4.0 Cr of spending on assets, ₹0.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −67% of profit came in as cash: the cash cycle got 31 days longer between FY10 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 31 days longer. The next section looks at where the cash is stuck. ## Where does Indokem's cash go? Indokem Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 79 days in FY26, up from 48 days in FY10. It spent ₹4.0 Cr on assets over the last 3 years. Customers take 92 days to pay, and stock sits for 115 days on average. At FY26 sales of ₹169 Cr, each day of that cycle ties up about ₹0.5 Cr, so roughly ₹37.0 Cr is tied up in the business at any time. FY26: customers took 92 days to pay and stock sat for 115 days, about 3.8 months of sales sitting as stock, for a full cycle of 79 days, longer than FY10's 48. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 115 days. Customers pay about 92 days after that. Suppliers are paid at 129 days. Together that makes the 79-day cycle. Spending on assets: ₹4.0 Cr over the last 3 years, against ₹7.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Indokem's P/E ratio, and how does it compare with its own history? Indokem Ltd's P/E is 782.1×, near the high end of its own history: higher than 87% of past readings. Its usual P/E (the middle reading) is 347.3×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −41.2% while the price moved −9.3%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Indokem business getting better or worse? Indokem Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Indokem earn on its capital? Indokem Ltd earned a ROCE of 5% in FY26. That is up from a low of −22% in FY11. Its return on capital used (ROIC) is 7.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 1.2% net margin and 1.17× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 1.2% net margin × 1.17× asset turnover × 2.23× leverage (assets divided by equity) ≈ 3.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 4.9% − 12.0% = −7.1 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Indokem have too much debt? Indokem Ltd has total debt of ₹27.0 Cr against shareholder equity of ₹65.0 Cr as of Jun 2026, so its debt is 0.42× its equity. Year by year, that ratio went from 0.34 in FY22 to 0.43 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Indokem shareholding pattern? No group of Indokem Ltd's owners changed its stake by a full percentage point over the last two years. Domestic institutions moved +0.0 points over the same period, to 0.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −0.1 points over 8 quarters, to 68.6%; Domestic institutions: +0.0 points over 8 quarters, to 0.2%. ## How far is Indokem from balance-sheet trouble? For Indokem Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Indokem rank in its industry? 29.8 out of 100, rank 10 of 10 in Dyes & Pigments, with 64% of the evidence available. Indokem Ltd scores 29.8 out of 100 against the 10 companies it is compared with in Dyes & Pigments, ranking 10. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 6.8 + 3.1 + 8.5 + 11.4 = 29.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Indokem compared with? Indokem ranks 10 of 10 Dyes & Pigments companies on the 4-Factor Sector Score, with 29.8 out of 100. 1. [Bhageria Industries Ltd](https://www.sectoralpha.in/stocks/bhageria-industries-ltd) BHAGERIA · leader · Most evidence points up · 82% evidence 69.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.5/35 · Revenue 75.8% · Profit 100% · Operating margin change 8 points · 95% evidence Capital efficiency 14.3/25 · ROCE 9.4% · Operating margin 19% · 76% evidence Valuation 9.2/20 · P/E 14× · PEG n/a · 50% evidence Relative strength 17.7/20 · Lead over its industry 45.6% · Lead over NIFTY 500 79% · 1 year 61.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 28.5 + 14.3 + 9.2 + 17.7 = 69.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Bodal Chemicals Ltd](https://www.sectoralpha.in/stocks/bodal-chemicals-ltd) BODALCHEM · breaking out · Most evidence points up · 89% evidence 68.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.5/35 · Revenue 27.6% · Profit 100% · Operating margin change 0 points · 88% evidence Capital efficiency 10.1/25 · ROCE 5.6% · Operating margin 10% · 100% evidence Valuation 14.3/20 · P/E 30.2× · PEG 0.39 · 65% evidence Relative strength 20.0/20 · Lead over its industry 79.6% · Lead over NIFTY 500 114.4% · 1 year 168.5% · 100% evidence · 10 of 12 weeks ahead Exact sum: 24.5 + 10.1 + 14.3 + 20 = 68.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Atul Ltd](https://www.sectoralpha.in/stocks/atul-ltd) ATUL · quiet · Evidence leans up · 100% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.8/35 · Revenue 18.1% · Profit 40.5% · Operating margin change -4 points · 100% evidence Capital efficiency 19.3/25 · ROCE 14.9% · Operating margin 13% · 100% evidence Valuation 16.2/20 · P/E 19.2× · PEG 0.47 · 100% evidence Relative strength 0.0/20 · Lead over its industry -35.1% · Lead over NIFTY 500 -16.5% · 1 year -12.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.8 + 19.3 + 16.2 + 0 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Vidhi Specialty Food Ingredients Ltd](https://www.sectoralpha.in/stocks/vidhi-specialty-food-ingredients-ltd) VIDHIING · losing its lead · Evidence leans up · 85% evidence 55.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.8/35 · Revenue 34.4% · Profit 22.4% · Operating margin change -5 points · 100% evidence Capital efficiency 21.8/25 · ROCE 18.8% · Operating margin 19% · 100% evidence Valuation 5.3/20 · P/E 25.5× · PEG 2.77 · 100% evidence Relative strength 9.3/20 · Lead over its industry n/a · Lead over NIFTY 500 1.3% · 1 year -9% · 25% evidence · 10 of 12 weeks ahead Exact sum: 18.8 + 21.8 + 5.3 + 9.3 = 55.2 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 5. [Ultramarine & Pigments Ltd](https://www.sectoralpha.in/stocks/ultramarine-pigments-ltd) ULTRAMAR · quiet · Evidence leans up · 81% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue 15.6% · Profit 16.5% · Operating margin change 2 points · 88% evidence Capital efficiency 15.6/25 · ROCE 10.8% · Operating margin 19% · 100% evidence Valuation 9.6/20 · P/E 11.4× · PEG 2.42 · 100% evidence Relative strength 7.9/20 · Lead over its industry n/a · Lead over NIFTY 500 -10.2% · 1 year -22.3% · 25% evidence · 7 of 12 weeks ahead Exact sum: 20.5 + 15.6 + 9.6 + 7.9 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Kiri Industries Ltd](https://www.sectoralpha.in/stocks/kiri-industries-ltd) KIRIINDUS · breaking out · Evidence leans down · 71% evidence 49.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 25% · Profit 100% · Operating margin change 13 points · 83% evidence Capital efficiency 5.3/25 · ROCE 3.4% · Operating margin 5% · 76% evidence Valuation 11.5/20 · P/E 4.4× · PEG n/a · 15% evidence Relative strength 12.3/20 · Lead over its industry -4.7% · Lead over NIFTY 500 21.4% · 1 year 1% · 100% evidence · 11 of 12 weeks ahead Exact sum: 20.7 + 5.3 + 11.5 + 12.3 = 49.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Sudarshan Colorants India Ltd](https://www.sectoralpha.in/stocks/sudarshan-colorants-india-ltd) SUDARCOLOR · turning · Evidence leans down · 100% evidence 47.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue 6.3% · Profit -9.8% · Operating margin change 3 points · 100% evidence Capital efficiency 11.9/25 · ROCE 11.4% · Operating margin 13% · 100% evidence Valuation 17.6/20 · P/E 14.5× · PEG 0.47 · 100% evidence Relative strength 6.7/20 · Lead over its industry -20.5% · Lead over NIFTY 500 2% · 1 year -28.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 11.2 + 11.9 + 17.6 + 6.7 = 47.4 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Sudarshan Chemical Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-chemical-industries-ltd) SUDARSCHEM · breaking out · Evidence leans down · 81% evidence 44.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.6/35 · Revenue 90.2% · Profit 2.3% · Operating margin change 2 points · 88% evidence Capital efficiency 8.4/25 · ROCE 5.5% · Operating margin 10% · 100% evidence Valuation 6.4/20 · P/E 78.1× · PEG 1.29 · 100% evidence Relative strength 11.1/20 · Lead over its industry n/a · Lead over NIFTY 500 5.5% · 1 year -13.7% · 25% evidence · 12 of 12 weeks ahead Exact sum: 18.6 + 8.4 + 6.4 + 11.1 = 44.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Sadhana Nitro Chem Ltd](https://www.sectoralpha.in/stocks/sadhana-nitro-chem-ltd) SADHNANIQ · quiet · Most evidence points down · 71% evidence 32.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.1/35 · Revenue -24.3% · Profit -80% · Operating margin change 646.8 points · 74% evidence Capital efficiency 4.0/25 · ROCE -11.1% · Operating margin 17.9% · 100% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 6.3/20 · Lead over its industry -16.2% · Lead over NIFTY 500 5% · 1 year 13.1% · 100% evidence · 5 of 12 weeks ahead Exact sum: 12.1 + 4 + 10 + 6.3 = 32.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Indokem Ltd this page INDOKEM · breaking out · Most evidence points down · 64% evidence 29.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 6.8/35 · Revenue -4.5% · Profit -57.5% · Operating margin change 0.5 points · 88% evidence Capital efficiency 3.1/25 · ROCE 5.5% · Operating margin 4.8% · 100% evidence Valuation 8.5/20 · P/E 799× · PEG n/a · 15% evidence Relative strength 11.4/20 · Lead over its industry n/a · Lead over NIFTY 500 8.2% · 1 year -7.2% · 25% evidence · 5 of 5 weeks ahead Exact sum: 6.8 + 3.1 + 8.5 + 11.4 = 29.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Dyes & Pigments](https://www.sectoralpha.in/sectors/dyes-pigments), all 10 compared on one page. ## Which companies are close to Indokem in size? Indokem is the 5th largest of 10 Dyes & Pigments companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Sudarshan Chemical Industries, Kiri Industries and Bodal Chemicals. Just below it: Bhageria Industries, Vidhi Specialty Food Ingredients and Ultramarine & Pigments. ### Dyes & Pigments companies close in size 1. [Sudarshan Chemical Industries Ltd](https://www.sectoralpha.in/stocks/sudarshan-chemical-industries-ltd) ₹7,930 crore 2. [Kiri Industries Ltd](https://www.sectoralpha.in/stocks/kiri-industries-ltd) ₹3,513 crore 3. [Bodal Chemicals Ltd](https://www.sectoralpha.in/stocks/bodal-chemicals-ltd) ₹2,072 crore 4. Indokem Ltd ₹1,790 crore 5. [Bhageria Industries Ltd](https://www.sectoralpha.in/stocks/bhageria-industries-ltd) ₹1,582 crore 6. [Vidhi Specialty Food Ingredients Ltd](https://www.sectoralpha.in/stocks/vidhi-specialty-food-ingredients-ltd) ₹1,538 crore 7. [Ultramarine & Pigments Ltd](https://www.sectoralpha.in/stocks/ultramarine-pigments-ltd) ₹1,027 crore [All 10 Dyes & Pigments companies, largest first](https://www.sectoralpha.in/sectors/dyes-pigments#all-companies) ### Companies close in size in other industries 1. [Geojit Financial Services Ltd](https://www.sectoralpha.in/stocks/geojit-financial-services-ltd) ₹1,797 crore · Finance - Capital Markets - Brokers 2. [G M Breweries Ltd](https://www.sectoralpha.in/stocks/g-m-breweries-ltd) ₹1,795 crore · Alcoholic Beverages 3. Indokem Ltd ₹1,790 crore 4. [Khazanchi Jewellers Ltd](https://www.sectoralpha.in/stocks/khazanchi-jewellers-ltd) ₹1,786 crore · Diamond, Gems & Jewellery 5. [Honda India Power Products Ltd](https://www.sectoralpha.in/stocks/honda-india-power-products-ltd) ₹1,777 crore · Capital Goods - Electric General ## What else do people ask about Indokem? ### What is Indokem's share price today? Indokem Ltd's share price is ₹628.40, −9.3% over the past year. The whole company is worth ₹1,752 Cr on the market. In the last 52 weeks it traded between ₹463 to ₹878; today it is 40% of the way up from the low, 7.9% above its 200-day average (as of 3 November 2026). ### What were Indokem's latest quarterly results? Indokem Ltd reported revenue of ₹46.6 Cr and net profit of ₹1.1 Cr for the Jun 2026 quarter. Revenue rose 12.2% and profit rose 52.9% compared with a year earlier. Earnings per share were ₹0.38. The operating margin was 4.8%, 0.5 percentage points higher than a year earlier (as of 3 November 2026). ### What is Indokem's market cap? Indokem Ltd's market capitalisation is ₹1,752 Cr at a share price of ₹628.40. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Indokem performing? Indokem Ltd's share price has been rising for 11 weeks. In its latest quarter, revenue rose 12.2% and profit rose 52.9% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 10 weeks running (as of 3 November 2026). ### Will Indokem's share price go up? This page does not forecast Indokem Ltd's share price. What it shows instead: the share price is ₹628.40, and it has been rising for 11 weeks. Its P/E of 782.1× is higher than 87% of its own last 2 years (as of 3 November 2026). ### Who owns Indokem? Promoters own 68.6% of Indokem Ltd, foreign institutions , domestic institutions 0.2% and the public 31.2% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is Indokem in its business cycle? Indokem Ltd's FY26 operating margin was 2.8%, against a 10-year range of −41.0% to 10.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 4.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Indokem story? The main question: profits are rising, but only −67% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Indokem a stock worth studying right now? What the numbers show: Indokem Ltd's share price has risen faster than its earnings: −9.3% in a year, against −41.2% for earnings per share. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists - Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india This is research, not advice. We’re not SEBI-registered.